Statin treatment: myths and reality

Statin treatment: myths and reality

Aim. To assess effectiveness and tolerability of rosuvastatin treatment, as a part of primary and secondary cardiovascular prevention, in patients with high and very high cardiovascular risk and dyslipidemia.Material and methods. Forty patients received rosuvastatin (starting dose 10 mg/d) for 12 we...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. A. Malay, B. V. Sharykin, A. N. Miroshnichenko, V. V. Konurovsky, E. E. Kusnetsova, O. I. Vasina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atherosclerosis dyslipoproteinemia treatment statins effectiveness safety
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1540
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Statin safety: myths and reality
by: Zh. D. Kobalava, et al.
Published: (2007-04-01)

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015-09-01)

Combined treatment of dyslipoproteinemia in patients with atherosclerosis
by: K. K. Mirchuk
Published: (2017-06-01)

STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY
by: Y. A. Karpov
Published: (2015-12-01)

METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS
by: E. I. Yakovenko, et al.
Published: (2012-04-01)

Statins: Evidence for effectiveness
by: K. Outhoff
Published: (2014-09-01)

DISORDERS OF PLASMA AND PLATELET PATHWAYS OF HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH DISLIPOPROTEINEMIA
by: M. Y. Zhuk, et al.
Published: (2003-10-01)

DISTURBANCES OF LIPID METABOLISM
by: P. F. Litvitskii
Published: (2012-11-01)

Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis
by: M. V. Klimushina, et al.
Published: (2016-11-01)

Pharmacological Profile and Mechanisms of Cardiovascular Protective Effects of Statins: An Update
by: Abdalla Salem Elhwuegi, et al.
Published: (2025-06-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015-11-01)

Statins and the risk of cataract
by: E. K. Butina, et al.
Published: (2019-12-01)

Statin therapy in atherosclerosis prevention: modern strategy and tactics
by: M. G. Bubnova
Published: (2009-06-01)

APPROACHES TO STATIN THERAPY ADHERENCE IMPROVEMENT
by: S. A. Shalnova, et al.
Published: (2018-04-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Prevalence and predictors of statin therapy in the general working-age population
by: V. S. Kaveshnikov, et al.
Published: (2020-07-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Statin use and risk of diabetes mellitus
by: Oksana Mikhailovna Drapkina, et al.
Published: (2012-06-01)

We act as early as possible and prescribe for as long as possible! Individualised approach to statin therapy
by: M. V. Chirkova
Published: (2024-11-01)

Karotid Endarterektomi geçiren hastalarda kontrolsüz diyabetin statin kullanan ve kullanmayan hastalarda LDL seviyelerine etkisi
by: Ateş Duman, et al.
Published: (2016-06-01)

Statin therapy in patients with high and very high cardiovascular risk: an optimal approach
by: E. V. Sayutina, et al.
Published: (2020-11-01)

Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01)

ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE
by: A. I. Chesnikova, et al.
Published: (2015-12-01)

Combination of statin and ezetimibe in the post-infarction period
by: Valentin E. Oleynikov, et al.
Published: (2024-12-01)

Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
by: I. A. Latfullin, et al.
Published: (2015-12-01)

Statins in arterial hypertension treatment
by: O. N. Tkacheva, et al.
Published: (1970-01-01)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
by: I. V. Shirinsky, et al.
Published: (2014-07-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
by: N. V. Izmozherova, et al.
Published: (2020-07-01)

METABOLIC STATUS IN YOUNG AND MIDDLE-AGED WOMEN SUFFERING FROM CORONARY ARTERY DISEASE
by: A. D. Kuimov, et al.
Published: (2003-12-01)

Modern algorithms for statin therapy
by: V. A. Susekov
Published: (2023-11-01)

COMPLEX ASSESSMENT OF EFFICACY OF STATINS PRESCRIBED AT MOST BY CLINICIANS
by: A. S. Sivkov, et al.
Published: (2018-06-01)

Prognostic value of homocysteine and vitamin D for patients with ischemic heart disease and multifocal atherosclerosis
by: O. S. Nykonenko, et al.
Published: (2018-02-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Platelet aggregation, dyslipoproteinemia and polyunsaturated fatty acids
by: E. I. Sokolov, et al.
Published: (2006-10-01)

Statins in clinical practice
by: A. S. Sivkov, et al.
Published: (2010-04-01)

A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol
by: K. P. Raevskii, et al.
Published: (2025-06-01)

Statins: Adherence and side-effects
by: D.J. Blom
Published: (2011-07-01)

Circulatory disease pathogenesis
by: E. N. Vorobyeva, et al.
Published: (2006-10-01)

Statins and their antiarrhythmic activity
by: N. Sh. Zagidullin, et al.
Published: (1970-01-01)